1. P Jordan - Editorial
2. P Jordan/ P Matos (INSA, Lisbon) - BRAF mutant and MSI-type
3. Raquel Seruca/Sofia Fernandes (IPATIMUP, Porto) - PI3K as therapeutic target
4. Eric Chastre/ L Kotelevets (INSERM Paris) - targeting PTEN in CRC
5. Luis Costa/Marta Martins (Hospital S Maria, Lisbon) -...
číst celé
1. P Jordan - Editorial
2. P Jordan/ P Matos (INSA, Lisbon) - BRAF mutant and MSI-type
3. Raquel Seruca/Sofia Fernandes (IPATIMUP, Porto) - PI3K as therapeutic target
4. Eric Chastre/ L Kotelevets (INSERM Paris) - targeting PTEN in CRC
5. Luis Costa/Marta Martins (Hospital S Maria, Lisbon) - Clinical response and resistance to EGFR therapy
6. Cecilia Rodrigues (F Pharmacy, Lisbon) - miRNAs as modulators of EGFR therapy
7. Jesus Garcia-Fonsillas (Madrid)- Targeting KRAS mutant CMS3 subtype by metabolic inhibitors
8. Targeting TGFb and subtype CMS4
9. Hugo Snippert/Carla Veríssimo (Utrecht, NL)- promise of patient-derived colon organoids in targeted therapy.
schovat popis
Recenze